These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 6721510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Experimental studies on the amplification of anti-tumor effects using bacterial DNA-treated cancer cells, immunoactivators and interferon].
    Kitasato M.
    Nihon Gan Chiryo Gakkai Shi; 1985 Jul 20; 20(6):1107-16. PubMed ID: 3934297
    [No Abstract] [Full Text] [Related]

  • 4. Effect of streptococcal preparation, OK-432, on experimental infection due to Mycobacterium lepraemurium in mice of C3H/Jms strain.
    Saito H, Tomioka H, Sato K.
    Hiroshima J Med Sci; 1983 Jun 20; 32(2):231-4. PubMed ID: 6352569
    [No Abstract] [Full Text] [Related]

  • 5. Cytolytic mechanism of attenuated preparation (OK-432) of Streptococcus Haemolyticus against ascites hepatoma, AH 130 and AH 41 C cells.
    Ogiso T, Masuda H, Seko M.
    Chem Pharm Bull (Tokyo); 1979 Jan 20; 27(1):166-75. PubMed ID: 428023
    [No Abstract] [Full Text] [Related]

  • 6. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. I. Experimental study using a rat model of malignant ascites].
    Umemoto T, Saji S, Minatsu H, Kunii Y, Goshima H, Tachibana S, Takao H, Sakata K.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun 20; 23(6):1229-35. PubMed ID: 3230342
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432].
    Mukae S, Norimura T, Tsuchiya T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun 25; 47(6):838-44. PubMed ID: 3684525
    [No Abstract] [Full Text] [Related]

  • 8. [A study of the synergy of microwave coagulation and streptococcal preparation (OK-432) in experimental tumors in relation to interleukin 2 producing activity].
    Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Egawa H, Noguchi H, Nagai Y, Kobayashi Y, Mori K.
    Nihon Geka Hokan; 1986 Sep 01; 55(5):689-99. PubMed ID: 3495246
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced resistance to Pseudomonas aeruginosa infection in mice pretreated with OK-432.
    Saito H, Watanabe T, Tomioka H, Sato K, Kitagawa T.
    Hiroshima J Med Sci; 1983 Jun 01; 32(2):235-9. PubMed ID: 6618904
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Consecutive, multimodal therapy of cancer: selective biological initiation (OK-432), cytoplasmic and nuclear damage (FT-207 and cyclophosphamide), inhibition of repair (bleomycin), and activation of cleansing and surveillance mechanisms.
    Okuyama S, Mishina H.
    Sci Rep Res Inst Tohoku Univ Med; 1981 Dec 01; 28(1-4):7-14. PubMed ID: 6179159
    [No Abstract] [Full Text] [Related]

  • 14. Immunochemotherapy prevents human colon cancer metastasis after orthotopic onplantation of histologically-intact tumor tissue in nude mice.
    Furukawa T, Kubota T, Watanabe M, Kuo TH, Kase S, Saikawa Y, Tanino H, Teramoto T, Ishibiki K, Kitajima M.
    Anticancer Res; 1993 Dec 01; 13(2):287-91. PubMed ID: 8517641
    [Abstract] [Full Text] [Related]

  • 15. [Selective intraarterial infusion of OK-432 in advanced malignancies].
    Sakamoto K, Ohtsuki S, Hasegawa M, Shimizu T, Sako M, Yuri H, Nishiwaki Y, Yokogawa S.
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb 20; 20(1):84-93. PubMed ID: 3998574
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of immunochemotherapy with streptococcal preparation "OK-432" on inoperable advanced cancers (author's transl)].
    Nio Y, Nitta N, Tanaka A, Ichikawa T, Henmi K.
    Nihon Geka Hokan; 1981 Sep 01; 50(5):704-10. PubMed ID: 7332399
    [No Abstract] [Full Text] [Related]

  • 17. [Nursing of a patient with ascites being treated with OK-432].
    Yamashita I, Hidaka M, Ikegawa H, Yuhara K, Mori C.
    Kango Gijutsu; 1989 Mar 01; 35(4):412-5. PubMed ID: 2754876
    [No Abstract] [Full Text] [Related]

  • 18. [Immune responses and clinical effects of OK-432 immunotherapy in lung neoplasms].
    Watanabe H, Komori Y, Yamada T, Iwa T.
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr 01; 27(4):451-8. PubMed ID: 469305
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of streptococcal preparation (OK-432) local injection in patients with urinary bladder carcinoma.
    Nishio S, Izeki T, Wada S, Morikawa Y, Yasumoto R, Maekawa M.
    Osaka City Med J; 1980 Apr 01; 26(1):47-59. PubMed ID: 7267092
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.